Package 59762-0405-4

Brand: risedronate sodium

Generic: risedronate sodium
NDC Package

Package Facts

Identity

Package NDC 59762-0405-4
Digits Only 5976204054
Product NDC 59762-0405
Description

4 TABLET, FILM COATED in 1 DOSE PACK (59762-0405-4)

Marketing

Marketing Status
Marketed Since 2002-05-17
Brand risedronate sodium
Generic risedronate sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a5de8cc0-48ec-41cc-99f1-87f1c432096d", "openfda": {"unii": ["HU2YAQ274O", "F67L43UT5C"], "rxcui": ["905024", "905028", "905092", "905100"], "spl_set_id": ["f715718a-407d-4e2a-9834-74a8f1361d03"], "manufacturer_name": ["Mylan Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 TABLET, FILM COATED in 1 DOSE PACK (59762-0405-4)", "package_ndc": "59762-0405-4", "marketing_start_date": "20020517"}], "brand_name": "Risedronate Sodium", "product_id": "59762-0405_a5de8cc0-48ec-41cc-99f1-87f1c432096d", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Bisphosphonate [EPC]", "Bisphosphonate [EPC]", "Diphosphonates [CS]", "Diphosphonates [CS]"], "product_ndc": "59762-0405", "generic_name": "Risedronate Sodium", "labeler_name": "Mylan Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Risedronate Sodium", "active_ingredients": [{"name": "RISEDRONATE SODIUM HEMIPENTAHYDRATE", "strength": "30.1 mg/1"}, {"name": "RISEDRONATE SODIUM MONOHYDRATE", "strength": "4.9 mg/1"}], "application_number": "NDA020835", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20020517", "listing_expiration_date": "20271231"}